E2 ModerateModerate confidencePEM not requiredMethods-PaperPeer-reviewedMachine draft
Establishing Clinically Relevant Severity Levels for the Central Sensitization Inventory.
Neblett, Randy, Hartzell, Meredith M, Mayer, Tom G et al. · Pain practice : the official journal of World Institute of Pain · 2017 · DOI
Quick Summary
Researchers created and tested a scoring system called the Central Sensitization Inventory (CSI) to help doctors identify when someone's symptoms may be caused by their nervous system being overly sensitive to pain signals. The study divided CSI scores into five levels—from subclinical to extreme—and confirmed that higher scores are associated with having more chronic conditions like fibromyalgia and ME/CFS, as well as higher levels of depression, sleep problems, and disability.
Why It Matters
This study provides ME/CFS patients and clinicians with a standardized, validated tool to quantify central sensitization severity and track treatment response. For ME/CFS researchers, these severity levels enable consistent stratification and comparison across studies, improving our ability to identify and study central sensitization as a potential contributing mechanism in ME/CFS.
Observed Findings
- CSS patient samples showed CSI score distributions skewed toward higher severity ranges compared to non-CSS patient samples.
- CSI mean scores progressively increased into higher severity levels as the number of individual CSS diagnoses increased.
- Patients scoring in the extreme CSI severity level (60–100) were significantly more likely to report prior diagnoses of fibromyalgia, ME/CFS, temporomandibular joint disorder, tension/migraine headaches, and anxiety or panic attacks (P<0.01).
- CSI severity levels showed significant associations with patient-reported depressive symptoms, perceived disability, sleep disturbance, and pain intensity (P≤0.02).
Inferred Conclusions
- The five-level CSI severity classification system is a valid and clinically useful tool for interpreting CSI scores in both healthcare and research settings.
- Higher CSI scores are associated with multiple concurrent CSS diagnoses and greater severity of comorbid psychosocial and physical symptoms.
- CSI severity levels may be useful for evaluating treatment responsiveness and stratifying patient populations in clinical trials.
Remaining Questions
- How well do CSI severity levels predict longitudinal outcomes, treatment response, or disease progression in ME/CFS and other CSSs?
- What are the underlying neurobiological mechanisms that the CSI is measuring, and do different CSS diagnoses share a common central sensitization mechanism?
What This Study Does Not Prove
This study validates a screening tool and does not establish that central sensitization causes ME/CFS or other central sensitivity syndromes—only that the CSI score correlates with their presence. It does not clarify the biological mechanisms underlying central sensitization or whether these severity levels predict prognosis or guide specific treatment decisions. The cross-sectional design means causality cannot be inferred from the observed associations.
Tags
Symptom:Cognitive DysfunctionUnrefreshing SleepPainFatigueSensory Sensitivity
Method Flag:PEM Not DefinedWeak Case DefinitionMixed Cohort
Metadata
- DOI
- 10.1111/papr.12440
- PMID
- 26989894
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →